BioNanomatrix Closes $23.3M Series B
BioNanomatrix Inc., a developer of nanoscale, single-molecule imaging and analysis platforms, has raised $23.3 million in Series B financing. Domain Associates led the round, with participation from new investor Gund Investment Corporation and existing shareholders Battelle Ventures, Innovation Valley Partners and KT Venture Group joining the round. Domain Associates has offices in Princeton, N.J., and San Diego.
18 March 2011•2 mins read
